Cited by 484Influenza Virus Research StudiesEvolution and Genetic DynamicsVirology and Viral Diseases

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift

Open access
Hensley, Scott E., Das, Suman R., Bailey, Adam L., Schmidt, Loren M., Hickman, Heather D., Jayaraman, Akila, Viswanathan, Karthik, Raman, Rahul +3 more·2009·Science

Abstract

Flu's Tricky Tricks: After vaccination against influenza A virus, single-point mutations are selected in hemagglutinin (the virus molecule that binds to sialic acid molecules on the surface of host cells) that escape neutralization by polyclonal antibody responses. Hensley et al. (p. 734 ) have discovered that in mice these mutations increased the virus's avidity for sialic acid. Amino acid substitutions that occur during reiterations of immune escape and avidity modulation can thus drive antigenic variation. This constant evolution of influenza viruses requires us to change vaccine components annually, and, for equine influenza, Park et al. (p. 726 ) show that as the match between virus and vaccine strains drifts apart with time, the probability of becoming infected and the length of the infectious period increase to the point where outbreaks occur. Nevertheless, even imperfect vaccines may be of benefit to a population because increasing the proportion of vaccinated individuals can supply enough herd immunity to offset a poor antigenic match, especially if used in conjunction with antiviral drugs. For humans, Yang et al. (p. 729 , published online 10 September) estimate that the rate of transmission within U.S. households puts influenza A 2009 H1N1 (the current pandemic “swine flu”) in the higher range of transmissibility, compared to past seasonal and pandemic strains. Thus, to achieve mitigation this fall, children should be the first recipients of vaccine, followed by adults—aiming overall for 70% coverage of the population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.1178258

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [1]Air GM Laver WG Webster RG Contrib Microbiol Immunol 1987 8 20 3304832

Cited by

Sorted by citations

Authors
Hensley, S. E., Das, S. R., Bailey, A. L., Schmidt, L. M., Hickman, H. D., Jayaraman, A., Viswanathan, K., Raman, R., Sasisekharan, R., Bennink, J. R., & Yewdell, J. W.
Affiliations
  • National Institute of Allergy and Infectious Diseases (US)
  • Harvard–MIT Division of Health Sciences and Technology (US)
Corresponding author
Yewdell, Jonathan W.
Venue
Science
Published
2009-10-30
Volume
326
Issue
5953
Pages
734-736
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W1539973467
Cited by
484
References
16
Citations by year
2026: 18 · 2025: 20 · 2024: 22 · 2023: 16 · 2022: 22 · 2021: 24 · 2020: 37 · 2019: 22 · 2018: 39 · 2017: 25 · 2016: 25 · 2015: 32 · 2014: 29 · 2013: 55 · 2012: 27
FWCI
21.71
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
  • PubMed Central
Funders
  • National Institutes of Health
  • National Institute of General Medical Sciences (U54-GM62116, GM 57073, U54GM062116)
  • National Institute of Allergy and Infectious Diseases (Z01AI001014)
Topics
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
Keywords
influenza A virus, hemagglutinin, antigenic drift, sialic acid, immune evasion, neutralizing antibodies, equine influenza, herd immunity, 2009 H1N1 pandemic, household transmission, vaccine prioritization, antiviral agents
MeSH terms
Animals, Antibodies, Viral, Antigenic Variation, Cell Line, Influenza Vaccines, Mice, Inbred BALB C, Mice, Inbred C57BL, Mutation, Receptors, Virus, Serial Passage, Models, Immunological, Hemagglutinin Glycoproteins, Influenza Virus, Mice, Influenza A Virus, H1N1 Subtype, Antibodies, Neutralizing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review